OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 28

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Chien‐Tai Hong, Jia‐Hung Chen, Chaur‐Jong Hu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10

An Update on the Potential of Tangeretin in the Management of Neuroinflammation-Mediated Neurodegenerative Disorders
Irshad Wani, Sushruta Koppula, A. C. Balda, et al.
Life (2024) Vol. 14, Iss. 4, pp. 504-504
Open Access | Times Cited: 8

Actions and Consequences of Insulin in the Striatum
Jyoti C. Patel, Kenneth D. Carr, Margaret E. Rice
Biomolecules (2023) Vol. 13, Iss. 3, pp. 518-518
Open Access | Times Cited: 13

The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Samo Ribarič
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4358-4358
Open Access | Times Cited: 5

Diabetes and Parkinson’s Disease: Understanding Shared Molecular Mechanisms
Annekatrin König, Tiago F. Outeiro
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 917-924
Open Access | Times Cited: 5

Parkinson’s Spectrum Mechanisms in Pregnancy: Exploring Hypothetical Scenarios for MSA in the Era of ART
Dušica Kovačević, Gordana Velikić, D Marić, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3348-3348
Open Access

Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease
Danni Wang, Shuhui Qu, Zaijun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

The impact of diabetes mellitus on the development of psychiatric and neurological disorders
Olivia G. Kelly, Jillian Sullivan, Natalie Carris, et al.
Brain Disorders (2024) Vol. 14, pp. 100135-100135
Open Access | Times Cited: 3

Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De, Yung‐Chih Kuo
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105401-105401
Closed Access | Times Cited: 2

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 1080-1109
Open Access | Times Cited: 6

Parkinson’s Disease and Diabetes Mellitus: Individual and Combined Effects on Motor, Cognitive, and Psychosocial Functions
Jolie Barter, Dwaina Thomas, Liang Ni, et al.
Healthcare (2023) Vol. 11, Iss. 9, pp. 1316-1316
Open Access | Times Cited: 5

The Anatomy and Clinical Significance of Sensory Disturbance in Parkinson's Disease
Benxu Ma, Jianying Zhang, Yanlei Cui, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 3
Open Access | Times Cited: 4

Innervation of the pancreas in development and disease
Rikke Hoegsberg Agerskov, Pia Nyeng
Development (2024) Vol. 151, Iss. 2
Closed Access | Times Cited: 1

Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease
Lars Tatenhorst, Fabian Maass, Hannah Paul, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Enhancement of Bone Repair in Diabetic Rats with Metformin‐Modified Silicified Collagen Scaffolds
Y Wang, Xiaoxia Zhang, X F Chen, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1

Metabolic Dysfunction in Parkinson’s Disease: Unraveling the Glucose–Lipid Connection
Jeswinder Sian‐Hülsmann, Peter Riederer, Tanja Maria Michel
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2841-2841
Open Access | Times Cited: 1

Azoramide prevents MPP+-induced dopaminergic neuronal death via upregulating ER chaperone BiP expression
Nana Ai, Danni Wang, Shuhui Qu, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 299-308
Open Access | Times Cited: 3

ESTUDIO MOLECULAR COMPARATIVO DE LA FRECUENCIA DE DENGUE Y ZIKA EN SUERO Y SALIVA DE MUJERES EN EDAD REPRODUCTIVA DEL ESTADO DE GUERRERO
Luz del Carmen Alarcón‐Romero, Ma. Isabel Zubillaga Guerrero, Carlos Ignacio Machain William, et al.
(2024), pp. 36-50
Open Access

A CONEXÃO CURIOSA ENTRE DIABETES MELLITUS E A DOENÇA DE PARKINSON
Laís Macêdo Maciel, Ana Vitoria Ferreira dos Santos, Caio Victor Barros Gonçalves da Silva, et al.
(2024), pp. 66-99
Open Access

FATORES QUE INFLUENCIAM NA PREMATURIDADE
Cristina Rosângela do Nascimento Carneiro, Camila Caroline Cabeça Reis, Renata Alves Dias, et al.
(2024), pp. 32-35
Open Access

IMUNOLÓGICOS ENVOLVIDOS NA PATOGÊNESE DA DOENÇA PERIODONTAL
Jordânia Marques de Oliveira Freire, Livya Maria Vasconcelos Lima Sousa, Ívina Alcântara Rodrigues, et al.
(2024), pp. 10-31
Open Access

Page 1 - Next Page

Scroll to top